Lilly Moves To Intervene In GLP-1 Compounding Pharmacies’ Suit Against FDA
FORT WORTH, Texas — Objections to a motion to intervene filed by Eli Lilly and Co. in a suit brought by companies representing the interests of drug compounders that challenge the...To view the full article, register now.
Already a subscriber? Click here to view full article